Skip to main content
. 2016 May 28;7(33):53895–53902. doi: 10.18632/oncotarget.9656

Figure 2. Elevated expression of BCDIN3D predictsworse clinical outcome in breast cancer patients, especially in TNBC.

Figure 2

a. Cumulative disease-free survival curves of patients with positive or negative expression of BCDIN3D in breast cancer patients. b. Cumulative disease-free survival curves of patients with positive or negative expression of BCDIN3D in TNBC patients.